Implementing Coordinated Specialty Care in CMHC Youth and Young Adults with Severe Mental Illness: Preliminary Outcome Assessment

Tanzer, Joshua Ray; Redding, Colleen A.; Mikhalyuk, Irena; Bennett, Bridget; Lamoureux, Barbara; Achin, Denise; Bassett, Shayna S.; Martin, Rosemarie A.; Stein, L. A. R.

doi:10.1007/s10597-020-00763-9

Cited by 3 publications

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Li et al [9] found that a shorter duration of untreated psychosis was predictive of better outcomes in a population of individuals experiencing their first episode of psychosis. Specialized treatment or coordinated specialty care (CSC)-an evidence-based, multidisciplinary team approach that includes medication and health support, psychotherapy, family education, peer support, supported education and employment, and case management-also seems to play a role in improving recovery rates in early intervention, and has been associated with higher rates of engagement and improvement in objective recovery measures [15]. For example, individuals diagnosed with early psychosis who received comprehensive care through the Recovery After an Initial Schizophrenia Episode (RAISE) Early Treatment Program experienced decreased hospitalization, improved quality of life, and increased involvement in work and school when compared to those who received community care [16].…”

Section: Introductionmentioning

confidence: 99%

Metacognition as a Transdiagnostic Determinant of Recovery in Schizotypy and Schizophrenia Spectrum Disorders

Wiesepape,

Smith,

Hillis-Mascia

et al. 2024

Behavioral Sciences

View full text Add to dashboard Cite

The term schizotypy refers to the latent personality organization that is thought to underpin the liability to develop schizophrenia and associated disorders. Metacognition, or the ability to understand and form increasingly complex and integrated ideas of oneself, others, and one’s community, has been proposed to be an important transdiagnostic construct across schizophrenia spectrum disorders and a range of both clinical and non-clinical manifestations of schizotypy. In this paper, we review evidence that deficits in metacognition are present in individuals with relatively high levels of schizotypy and that these deficits are related to symptomology, function, and quality of life. We address the idea that decrements in metacognition may also contribute to the progression from schizotypy to more severe manifestations, while the amelioration of these deficits may enhance aspects of recovery, including the ability to form an integrated sense of self, others, and the wider world. We also review the following two recovery-oriented psychotherapies that target metacognition to promote recovery in individuals with clinical manifestations of schizotypy: Evolutionary Systems Therapy for Schizotypy (ESTS) and Metacognitive Reflection and Insight Therapy (MERIT).

show abstract

Section: Introductionmentioning

confidence: 99%